These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 22770656)

  • 1. Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring.
    Agence française de sécurité sanitaire des produits de santé
    Med Mal Infect; 2012 Jul; 42(7):301-8. PubMed ID: 22770656
    [No Abstract]   [Full Text] [Related]  

  • 2. The aminoglycosides. Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, sisomicin.
    Edson RS; Keys TF
    Mayo Clin Proc; 1983 Feb; 58(2):99-102. PubMed ID: 6823164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of prospective, controlled clinical trials of gentamicin, tobramycin, amikacin, and netilmicin.
    Cone LA
    Clin Ther; 1982; 5(2):155-62. PubMed ID: 6760967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of resistance to netilmicin and other aminoglycosides.
    Toscano MA; Russo G; Nicoletti G; Stefani S; Geraci C; Alessandria E
    Chemioterapia; 1986 Jun; 5(3):191-5. PubMed ID: 3719853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of intermittent and continuous administration of aminoglycosides in the treatment of bronchopulmonary infections due to gram-negative bacteria.
    Klastersky J; Thys JP; Mombelli G
    Rev Infect Dis; 1981; 3(1):74-83. PubMed ID: 7013002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation, release and in-vitro antibacterial activity of liposomal aminoglycosides against Pseudomonas aeruginosa.
    Omri A; Ravaoarinoro M; Poisson M
    J Antimicrob Chemother; 1995 Oct; 36(4):631-9. PubMed ID: 8591937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in antimicrobial therapy.
    Parry MF
    Del Med J; 1978 Jan; 50(1):33-8. PubMed ID: 631383
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic drug monitoring of aminoglycosides in acute myeloid leukaemia patients.
    Mareville J; Gay J; Cliquennois E; Herbaux C; Pasquier F; Allorge D; Blondiaux N; Berthon C; Alfandari S
    Scand J Infect Dis; 2012 May; 44(5):398-401. PubMed ID: 22235869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical view of aminoglycoside antibiotics].
    Lüthy R
    Adv Clin Pharmacol; 1978; 15():119-26. PubMed ID: 676870
    [No Abstract]   [Full Text] [Related]  

  • 10. Surveillance of aminoglycoside resistance. European data.
    Van Landuyt HW; Boelaert J; Glibert B; Gordts B; Verbruggen AM
    Am J Med; 1986 Jun; 80(6B):76-81. PubMed ID: 3089007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial agents--Part II. The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, neomycin.
    Brewer NS
    Mayo Clin Proc; 1977 Nov; 52(11):675-9. PubMed ID: 336988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, and sisomicin.
    Edson RS; Terrell CL
    Mayo Clin Proc; 1987 Oct; 62(10):916-20. PubMed ID: 3657309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Netilmicin and tobramycin: comparative evaluation of pharmacokinetics, nephrotoxicity, and therapeutic efficacy in animal studies (author's transl)].
    Marre R; Abraham M; Freiesleben H; Sack K
    Arzneimittelforschung; 1979; 29(6):940-5. PubMed ID: 582788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A closer look at aminoglycosides.
    DeTorres OH
    Clin Ther; 1981; 3(6):399-412. PubMed ID: 7260986
    [No Abstract]   [Full Text] [Related]  

  • 17. Progressive increase in antibiotic resistance of gram-negative bacterial isolates. Walter Reed Hospital, 1976 to 1980: specific analysis of gentamicin, tobramycin, and amikacin resistance.
    Cross AS; Opal S; Kopecko DJ
    Arch Intern Med; 1983 Nov; 143(11):2075-80. PubMed ID: 6639227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of the sensitivity of Enterobacteriaceae and Pseudomonas aeruginosa with 4 aminoglycosides].
    Turgeon P; Lamothe F; Vincelette J; Gaudreau C; Bourgault AM; Turgeon F
    Union Med Can; 1984 Jun; 113(6):522-4. PubMed ID: 6435299
    [No Abstract]   [Full Text] [Related]  

  • 19. The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model.
    Dubé L; Caillon J; Jacqueline C; Bugnon D; Potel G; Asseray N
    Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2545-7. PubMed ID: 22395262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro studies with netilmicin, amikacin, gentamicin, sissomicin and tobramycin.
    Habwe V; Shadomy S
    J Antimicrob Chemother; 1979 Jan; 5(1):73-9. PubMed ID: 762007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.